1 in 78 women will be diagnosed with ovarian cancer.
Sachia, a patient and an energetic advocate for ovarian cancer research, and Dr. Drescher, a dedicated clinician and researcher, share something profound:
Together, through collaboration, the physician and the patient, the scientist and the survivor,
have the power to change the statistics.
The Powell Drescher Ovarian Cancer Research Foundation will award grants to fund compelling ovarian cancer research, while continuing to build a lasting endowment that funds research far into the future.
Successful grant applications will include an explanation of how the research will directly, or have the potential to directly, touch the patient/survivor, and involve an advocate(s) (defined as ovarian cancer patients, survivors, family members, caregivers, previvors, and other people touched by ovarian cancer) as an integral part of the research team.
Our 2026 Request for Abstracts is officially OPEN! We are pleased to announce the Pilot Grant Award to encourage preliminary research projects in all areas of ovarian cancer research including, but not limited to: cancer biology, genetics, early detection and prevention, treatment, cancer care delivery, and public health sciences. New concepts, novel approaches, and/or projects that extend previous discoveries and have potential to develop into larger projects are encouraged. Learn more about our grant application guidelines using the guide linked below.
Meet Drs. Connolly, Porac, and Mulas from the Fox Chase Cancer Center!
The team will study which proteins interact with the protein CDON, a protein found on the surface of ovarian cancer cells, to better understand how CDON promotes ovarian cancer cell growth, which could lead to therapies that interfere with CDON function to and promote ovarian cancer cell death.
A requirement of the POWER Grant is the inclusion of an ovarian cancer advocate as an integral part of the research team. Dr. Clare Porac, an ovarian cancer survivor, has provided her thoughts on the project and will continue to provide feedback on the data and communication to be shared about the study, and more, throughout the project.
We believe that the input of ovarian cancer survivors is critical to the success of ongoing research. Ovarian cancer survivors bring immense value to the research process but may lack the confidence to become involved, or understand how to reach the scientists.
Scientists have few avenues by which to meet survivors, yet the grant awards process increasingly benefits from (and sometimes requires) survivor involvement.
The Powell-Drescher Ovarian Cancer Research Foundation is working to bridge these gaps, and raise research money to combat this deadly disease.
Read more about our research advocacy program by clicking the button below.
Ovarian cancer advocates speak for all the women who no longer have that ability.
Many women are taken too soon after their ovarian cancer diagnosis, and many more are too sick to speak up for greater awareness of ovarian cancer or to tell how underfunded research is for this deadly disease.
We must be their voices to raise awareness of, and research funding for, ovarian cancer.
Ann O’Donnell Bury is one of the voices we share. The Powell-Drescher Ovarian Cancer Research Foundation is grateful to Ann’s family for naming the Foundation as a memorial option, and appreciates the donations made by many in Ann’s memory.
Ann O’Donnell Bury
October 20, 1968 – December 5, 2022
Our tax exempt status pursuant to 501(c)(3) has been approved
and is retroactive to our date of formation, May 17, 2022.
Donations made after that date may be treated as tax-deductible contributions.
EIN: 88-2355055
COPYRIGHT 2022 © Powell-Drescher Ovarian Cancer Research Foundation. ALL RIGHTS RESERVED.
January 31, 2017 is when Sachia was diagnosed.